Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For:	Bloomgarden Z. Liraglutide and calcitonin. J Diabetes 2010;2:223-4. [PMID: 21140545 DOI: 10.1111/j.1753-0407.2010.00079.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open

Number	Cited by Other Article(s)
1	Nicolau Ramis J, Masmiquel Comas L. [The new antidiabetic agents in the firing line.... safety reasons or witch hunt?]. ACTA ACUST UNITED AC 2011;59:1-8. [PMID: 22177885 DOI: 10.1016/j.endonu.2011.11.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2011] [Accepted: 11/21/2011] [Indexed: 02/06/2023] Abstract Collapse Key Words Collapse MESH Headings Animals Breast Neoplasms/chemically induced Breast Neoplasms/epidemiology Calcitonin/metabolism Carcinoma, Medullary/chemically induced Clinical Trials as Topic/statistics & numerical data Comorbidity Diabetes Mellitus, Type 2/drug therapy Diabetes Mellitus, Type 2/epidemiology Dipeptidyl Peptidase 4/physiology Disease Susceptibility Female Glucagon-Like Peptide 1/adverse effects Glucagon-Like Peptide 1/agonists Glucagon-Like Peptide 1/analogs & derivatives Humans Hypoglycemic Agents/adverse effects Hypoglycemic Agents/therapeutic use Hypoglycemic Agents/toxicity Infections/etiology Liraglutide Pancreatitis/chemically induced Pharmacovigilance Pioglitazone Pyrazines/adverse effects Risk Assessment Safety-Based Drug Withdrawals Sitagliptin Phosphate Species Specificity Thiazolidinediones/adverse effects Thiazolidinediones/toxicity Thyroid Neoplasms/chemically induced Triazoles/adverse effects Urinary Bladder Neoplasms/chemically induced Urinary Bladder Neoplasms/epidemiology Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Nicolau Ramis J, Masmiquel Comas L. [The new antidiabetic agents in the firing line.... safety reasons or witch hunt?]. ACTA ACUST UNITED AC 2011;59:1-8. [PMID: 22177885 DOI: 10.1016/j.endonu.2011.11.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2011] [Accepted: 11/21/2011] [Indexed: 02/06/2023]